DOI: 10.1055/s-00040811

Neurologie up2date

Referenz

Reilmann R, McGarry A, Grachev ID. et al. European Huntingtonʼs Disease Network, Huntington Study Group investigators.
Safety and efficacy of pridopidine in patients with Huntingtonʼs disease (PRIDE-HD): a phase 2, randomised, placebo-controlled, multicentre, dose-ranging study.

Lancet Neurol 2019;
18: 165-176

Bibliographische Angaben herunterladen

Aufrufen in:
Aufrufen in: